⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19292743 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL30319513 | 0.97 | ENPEP (0.58) | — | |
| Hydrochloric Acid SCHEMBL30319514 | 0.97 | ENPEP (0.58) | — | |
| SCHEMBL23924659 | 0.87 | ENPEP (0.54) | — | |
| SCHEMBL6668940 | 0.83 | — | — | |
| SCHEMBL7314519 | 0.82 | NAALAD2 (0.56) | — | |
| SCHEMBL10938417 | 0.82 | NAALAD2 (0.56) | — | |
| SCHEMBL443229 | 0.82 | NAALAD2 (0.56) | — | |
| 2S,4R-4-Methylglutamate SCHEMBL7064898 | 0.81 | SLC7A5 (0.68) | — | |
| 2S,4R-4-Methylglutamate SCHEMBL1133372 | 0.81 | SLC7A5 (0.68) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117343920-A | Aminotransferase, nucleic acid molecule, recombinant expression vector and application thereof | 浙江赞源生物技术有限公司 | 2024-01-05 | — | — | CN | claimed |
| CN-118434765-A | BCMA monoclonal antibodies and antibody-drug conjugates | 杭州多禧生物科技有限公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-117343920-A | Aminotransferase, nucleic acid molecule, recombinant expression vector and application thereof | 浙江赞源生物技术有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-116751135-A | Preparation method of Sakuba/valsartan sodium | 苏州东瑞制药有限公司 | 2023-09-15 | — | — | CN | disclosed |
| CN-108602785-B | Novel processes and intermediates | 诺华股份有限公司 | 2023-08-11 | — | — | CN | disclosed |
| CN-115772509-A | Transaminase mutant and coding gene and application thereof | 广东东阳光药业有限公司 | 2023-03-10 | — | — | CN | disclosed |
| CN-113453724-A | Sulfonylmaleimide-based linkers and corresponding conjugates | 皮埃尔法布雷医药公司 | 2021-09-28 | — | — | CN | disclosed |
| CN-110964759-B | Novel synthesis process of anti-heart-failure drug intermediate | 北京瑞莱博基医药科技有限公司 | 2021-04-09 | — | — | CN | disclosed |
| US-10752705-B2 | Oligosaccharide compositions and methods for producing thereof | CADENA BIO, INC. (US) | 2020-08-25 | — | — | US | disclosed |
| CN-106521716-B | Modification of continuous carbon fibers during precursor formation for composite materials with enhanced moldability | 通用汽车环球科技运作有限责任公司 | 2020-05-19 | — | — | CN | disclosed |
| CN-110964759-A | Novel synthesis process of anti-heart-failure drug intermediate | 北京瑞莱博基医药科技有限公司 | 2020-04-07 | — | — | CN | disclosed |
| CN-106521716-A | Modification of continuous carbon fibers during precursor formation for composites having enhanced moldability | 通用汽车环球科技运作有限责任公司 | 2017-03-22 | — | — | CN | disclosed |
| WO-2010010080-A1 | ARYL-SULPHONAMIDIC DIMERS AS METALLOPROTEASES INHIBITORS | BRACCO IMAGING SPA (IT) | 2010-01-28 | — | — | WO | disclosed |
| WO-2010010079-A1 | DIAGNOSTIC AGENTS SELECTIVE AGAINST METALLOPROTEASES | BRACCO IMAGING SPA (IT) | 2010-01-28 | — | — | WO | disclosed |
| US-20070072096-A1 | Negative curable dye-containing composition, color filter, and method of manufacturing the same | FUJI PHOTO FILM CO., LTD. | 2007-03-29 | — | — | US | disclosed |
| US-4966856-A | QUANTITATIVE ANALYSIS OF FLUID SAMPLES | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1990-10-30 | — | — | US | disclosed |